Abstract:Objective: To establish and verify a diagnostic model for distinguishing multiple sclerosis (MS) from other neurological diseases with similar symptoms by usingcerebrospinal fluid oligoclonal band (CSF-OCB)combined with IgG intrathecal synthesis indicators and biochemical markers. Methods: Multiple sclerosis (MS) patients admitted to the Neurology Department of Beijing Tiantan Hospital affiliated with Capital Medical University from January 2014 to December 2022 were selected as the case group, while patients with similar neurological symptoms were selected as the control group. Using the case-control study design, a retrospective analysis was conducted on the detection of age, gender, oligoclonal bands in cerebrospinal fluid, IgG intrathecal synthesis indicators and biochemical indicators for all study subjects. The differential diagnosis model was determined by the multiple logistic regression analysis, and the receiver operating characteristic (ROC) curve was used to analyze the diagnostic efficiency of the differential diagnosis model for neurological diseases with similar symptoms to MS and other conditions. Results: This study included 167 patients in the case group and 335 patients in the control group, of which 128 patients in the case group and 265 patients in the control group were used to construct the model, and 39 patients in the case group and 70 patients in the control group were used for model validation. The differential diagnostic model constructed by a multivariate logistic regression model was Y=0.871×CSF-OCB-0.051×CSFprotein-0.231×CSFchloride+1.183×gender-0.036×LDH+35.770. The model showed that the area under the curve, sensitivity and specificity were respectively 0.916, 87.3% and 87.6%. The Delong test results showed that the diagnostic efficacy of the model was significantly different from OCB, IgG intrathecal synthesis indicators, and OCB combined with IgG intrathecal synthesis indicators (P<0.05). The new model validation showed that the actual diagnostic consistency rate for the MS group was 84.6%, while the actual diagnostic consistency rate for the control group was 90.0%. Conclusion: This study combines OCB, IgG intrathecal synthesis indicators, and biochemical indicators to establish a diagnostic prediction model for neurological diseases with similar clinical symptoms in MS. This model may have good differential diagnostic value and can better assist clinical diagnosis in the early stages of disease progression in MS patients.

Potential Fluid Biomarkers and a Prediction Model for Better Recognition Between Multiple System Atrophy-Cerebellar Type and Spinocerebellar Ataxia

A Wearable Multi-sensor System for Classification of Multiple System Atrophy and Parkinson's Disease

Candidate biomarkers of multiple system atrophy in cerebrospinal fluid

Prediction of Early-Wheelchair Dependence in Multiple System Atrophy Based on Machine Learning Algorithm: A Prospective Cohort Study

Improving the Accuracy of Diagnosis for Multiple-System Atrophy Using Deep Learning-Based Method

Diagnostic utility of fluid biomarkers in multiple system atrophy: a systematic review and meta-analysis

Systematic assessment of plasma biomarkers in spinocerebellar ataxia

New Model for Estimation of the Age at Onset in Spinocerebellar Ataxia Type 3

Prediction of the Age at Onset of Spinocerebellar Ataxia Type 3 with Machine Learning

Visual Prediction of the Progression of Spinocerebellar Ataxia Type 3 Based on Machine Learning

Predicting the Prognosis of Multiple System Atrophy Using Cluster and Principal Component Analysis.

Head-to-head comparison of 6 plasma biomarkers in early multiple system atrophy

Surface-Based Neuroimaging Pattern of Multiple System Atrophy

Explainable Artificial Intelligence Based on Feature Optimization for Age at Onset Prediction of Spinocerebellar Ataxia Type 3.

Altered Brain Volume, Microstructure Metrics and Functional Connectivity Features in Multiple System Atrophy

[The combined application of oligoclonal bands in cerebrospinal fluid and IgG intrathecal synthesis indicators and biochemical markers in the diagnosis of multiple sclerosis]

Survival analysis and prognostic nomogram model for multiple system atrophy.

Data-driven subtype classification of patients with early-stage multiple system atrophy

Mitochondria-Related Candidate Genes and Diagnostic Model to Predict Late-Onset Alzheimer's Disease and Mild Cognitive Impairment

Diagnostic utility of movement disorder society criteria for multiple system atrophy

Peripheral Inflammatory and Immune Landscape in Multiple System Atrophy: A Cross-Sectional Study